Dr. Fathima Zahra Kamil Faiz, MD

Dr. Kamil Faiz practices at Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System.

Dr. Kamil Faiz's NPI, 1972919355, was assigned on July 7, 2014. Dr. Kamil Faiz holds California license 146302.

Dr. Kamil Faiz's primary practice is Long Beach Medical Center, at 2801 Atlantic Ave, Long Beach, CA 90806 in Los Angeles County. The practice phone is (562) 933-2000.

Dr. Kamil Faiz's primary practice is Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System. The medical group on file is Inpatient Specialist of California PC. Dmand AI also links Dr. Kamil Faiz to 4 more group practices and clinics, 3 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamil Faiz practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kamil Faiz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kamil Faiz is licensed in California.

CMS data shows 1,292 Medicare services from Dr. Kamil Faiz across 7 procedure codes in 2024, for 382 Medicare patients. Medicare paid $117,393 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 382 Medicare patients who saw Dr. Kamil Faiz in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 3.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamil Faiz's median patient age at 68, with 48% women.

In 2024, Dr. Kamil Faiz wrote 405 Medicare Part D claims for 167 patients. 80% of them were for generic drugs. CMS names the drug for 144 of them, across 8 drugs with 11 or more claims each, at $33,303 in total drug cost. In 2023, CMS named 107 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kamil Faiz for performance year 2024, reported individually. Dr. Kamil Faiz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Kamil Faiz from 3 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $50.